Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10010380HBVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30006783HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30002433HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30006784HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30006785HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30019211HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS30017672HIVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS20021678HPVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS20067425HPVENSG00000103222.20protein_codingABCC1NoNo4363P33527
TVIS44029059HTLV-1ENSG00000103222.20protein_codingABCC1NoNo4363P33527
TCGA Plot Options
Drug Information
GeneABCC1
DrugBank IDDB04851
Drug NameBiricodar
Target IDBE0000785
UniProt IDP33527
Regulation Type
PubMed IDs15014037
CitationsMinderman H, O'Loughlin KL, Pendyala L, Baer MR: VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Clin Cancer Res. 2004 Mar 1;10(5):1826-34.
GroupsInvestigational
Direct Classification
SMILESCOC1=CC(=CC(OC)=C1OC)C(=O)C(=O)N1CCCC[C@H]1C(=O)OC(CCCC1=CN=CC=C1)CCCC1=CN=CC=C1
Pathways
PharmGKBPA164924560
ChEMBLCHEMBL350775